A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor

Angiogenesis plays an essential role in several diseases of the eye and in the growth of solid tumors, but existing antiangiogenic therapies have limited benefits in several cases. We report the antiangiogenic effects of a monoclonal antibody, CL1-R2, in several animal models of neovascularization....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 2011-05, Vol.208 (5), p.973-986
Hauptverfasser: Chabot, Sophie, Jabrane-Ferrat, Nabila, Bigot, Karine, Tabiasco, Julie, Provost, Alexandra, Golzio, Muriel, Noman, Muhammad Zaeem, Giustiniani, Jérôme, Bellard, Elisabeth, Brayer, Stéphanie, Aguerre-Girr, Maryse, Meggetto, Fabienne, Giuriato, Sylvie, Malecaze, François, Galiacy, Stéphane, Jaïs, Jean-Philippe, Chose, Olivier, Kadouche, Jean, Chouaib, Salem, Teissié, Justin, Abitbol, Marc, Bensussan, Armand, Le Bouteiller, Philippe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!